Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism DWORF modulators(small transmembrane regulator of ion transport 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Dilated | Preclinical | - | 23 Jan 2024 | |
Heart failure with reduced ejection fraction | Preclinical | - | 23 Jan 2024 |